Aseptic Technologies’ Crystal Closed Vial Technology reduces the risk of contamination during the compounding process, using lasers to reseal vials once they have been filled with medication.
“This technology represents a revolutionary advance for Cantrell Drug Company, as well as for the sterile product industry in general,” said Dell McCarley, CEO of Cantrell Drug Company.
More articles on pharmaceuticals:
FDA warns not to use sterile products from Downing Labs due to lack of quality assurance
340B Program: Time to recertify
Pharma recalls steady, but increasing in complexity
